Multi-country non-interventional study on the effectiveness and safety of Empagliflozin in adult patients with type 2 diabetes in Europe and Asia

21/01/2019
13/11/2026
EU PAS number:
EUPAS27606
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.12 MB - PDF) View document
Updated protocol
English (1.12 MB - PDF) View document
Study results
Study results
English (639.71 KB - PDF) View document
Study report
No information provided.
ENCePP Seal
No information provided.